Dr. Andrew McPartlin, MD
Claim this profilePrincess Margaret Cancer Center
Studies Prostate Cancer
Studies Squamous Cell Carcinoma
3 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Andrew McPartlin, MD is currently running
MRI + Biomarkers
for Throat Cancer
The purpose of this study is to explore biomarker development in patients with newly diagnosed Head and neck squamous cell carcinoma (HNSCC) receiving curative therapy.
Recruiting1 award N/A9 criteria
Enzalutamide + Standard Therapy
for Prostate Cancer
This trial is testing if adding enzalutamide, a pill that blocks male hormones, to standard radiation and hormone treatments can improve the quality of life for prostate cancer patients. Participants will receive treatments and be monitored over several months and years to see how they do. Enzalutamide is an antiandrogen used to treat both metastatic and nonmetastatic prostate cancer.
Recruiting2 awards Phase 29 criteria
More about Andrew McPartlin, MD
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Andrew McPartlin, MD has experience with
- ADT
- Enzalutamide
- Standard Of Care SBRT
- Head And Neck MRI
- Oral Pimonidazole
- SABR
Breakdown of trials Andrew McPartlin, MD has run
Prostate Cancer
Squamous Cell Carcinoma
Renal Cell Carcinoma
Kidney Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew McPartlin, MD specialize in?
Andrew McPartlin, MD focuses on Prostate Cancer and Squamous Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Andrew McPartlin, MD currently recruiting for clinical trials?
Yes, Andrew McPartlin, MD is currently recruiting for 3 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Andrew McPartlin, MD has studied deeply?
Yes, Andrew McPartlin, MD has studied treatments such as ADT, Enzalutamide, Standard of Care SBRT.
What is the best way to schedule an appointment with Andrew McPartlin, MD?
Apply for one of the trials that Andrew McPartlin, MD is conducting.
What is the office address of Andrew McPartlin, MD?
The office of Andrew McPartlin, MD is located at: Princess Margaret Cancer Center, Toronto, Ontario M5G 2M9 Canada. This is the address for their practice at the Princess Margaret Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.